Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (4)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (1)
- Big Data (1)
- Bioenergy (9)
- Biology (14)
- Biomedical (6)
- Biotechnology (3)
- Buildings (2)
- Chemical Sciences (2)
- Clean Water (3)
- Climate Change (3)
- Computer Science (14)
- Coronavirus (2)
- Cybersecurity (1)
- Decarbonization (3)
- Energy Storage (5)
- Environment (21)
- Exascale Computing (2)
- Frontier (1)
- Fusion (1)
- Grid (1)
- High-Performance Computing (9)
- Isotopes (6)
- ITER (1)
- Materials (4)
- Materials Science (6)
- Mercury (3)
- Microscopy (3)
- Nanotechnology (3)
- National Security (4)
- Neutron Science (6)
- Nuclear Energy (4)
- Physics (2)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (4)
- Security (2)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (7)
- Transportation (6)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.